Filed before 2025Filed 20 June 2023
Biopharmaceutical Research Co has sold $23.2M so far
Biopharmaceutical Research Co, a technology company based in Castroville, CA, has sold $23.2M so far in its convertible round, according to a filing dated 20 June 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 20 June 2023
- First filed
- 14 July 2022
- Round
- Convertible round (amended filing)
- Amount sold
- $23.2M
- Offering size
- $23.2M
- Investors so far
- 36
- Based in
- Castroville, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 81% of the 1,396 tracked raises with an amount filed in 2023, and than 83% of the 707 in technology.
Biopharmaceutical Research Co in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 20 Jun 2023 | Amended filing | $23.2M | This raise |
| 14 Jul 2022 | New filing | $10.2M | This raise |
More with Intrinsic Health on the board
- NextEvo, Inc.$725K
- ReliantHeart Inc.$3.86M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.